Highlights
•
Increasing cases of rhino-orbital mucormycosis in people with COVID-19 are being recently reported.

•
So far 101 cases of mucormycosis in patients with COVID-19 have been reported of which 82 cases belong to India.

•
Diabetes was present in 80% of cases, while corticosteroid treatment was given for COVID-19 in 76.3% cases.

People at Risk & Prevention CDC
https://www.cdc.gov/fungal/diseases/mucormycosis/risk-prevention.html

Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India
https://www.sciencedirect.com/science/article/pii/S1871402121001570